跳至主要内容
临床试验/ACTRN12618001717246
ACTRN12618001717246已完成未知

The effectiveness of a novel multidisciplinary therapy program on clinical and biological measures of disease progression in individuals with Huntington's disease.

Edith Cowan University0 个研究点目标入组 40 人开始时间: 2018年10月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • Inclusion criteria for premanifest HD individuals were a cytosine-adenine-guanine (CAG) repeat length > 39 and a diagnostic confidence score < 4 on the Unified Huntington’s Disease Rating Scale Total Motor Score (UHDRS-TMS) (Reilmann et al., 2014).

排除标准

  • Exclusion criteria were the presence of known musculoskeletal, metabolic, endocrine or cardiovascular disorders, recent or long-standing substance abuse, shift work other neurological conditions.

研究者

相似试验